Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

263.52
+2.290.87%
Post-market: 263.520.00000.00%16:51 EDT
Volume:443.60K
Turnover:116.83M
Market Cap:17.44B
PE:20.33
High:266.34
Open:263.34
Low:259.48
Close:261.23
52wk High:282.15
52wk Low:186.05
Shares:66.19M
Float Shares:65.54M
Volume Ratio:0.65
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):12.96
EPS(LYR):-4.4176
ROE:118.78%
ROA:9.58%
PB:10.46
PE(LYR):-59.65

Loading ...

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism

GlobeNewswire
·
Jun 14

MBX's Flagship Drug Trial Met Expectations But Perhaps Some Investors Wanted More -- Market Talk

Dow Jones
·
Jun 13

European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week

MT Newswires Live
·
Jun 12

Ascendis says Phase 2 trial shows TransCon PTH sustains hypoparathyroidism benefits at 5 years

Reuters
·
Jun 12

5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism

GlobeNewswire
·
Jun 12

Ascendis Pharma ‘oversold’ following ITC development, says Oppenheimer

TIPRANKS
·
Jun 09

Ascendis presents final Phase 3 PaTHway results for palopegteriparatide in adult hypoparathyroidism at ENDO 2026

Reuters
·
Jun 09

Ascendis Pharma to present rare endocrine disease data at Endocrine Society ENDO meeting

Reuters
·
Jun 09

Ascendis Pharma CFO Scott Thomas Smith acquires 100 common shares valued at $21,900

Reuters
·
Jun 03

Ascendis Pharma director Jean Jacques Bienaime acquires USD 111,986 in common shares

Reuters
·
Jun 02

Ascendis Pharma CFO Scott Thomas Smith acquires $55,830 of ordinary shares

Reuters
·
Jun 02

Ascendis Pharma director Jean Jacques Bienaime reports purchase of ordinary shares worth $95,120.5

Reuters
·
May 28

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

MT Newswires Live
·
May 26

J.P. Morgan Remains a Buy on Ascendis Pharma (ASND)

TIPRANKS
·
May 20

Ascendis Pharma Initiated at Buy by Citigroup

Dow Jones
·
May 19

Assessing Ascendis Pharma (ASND) Valuation After Recent Soft Trading And Perceived Discount

Simply Wall St.
·
May 19

Ascendis Pharma initiated with a Buy at Citi

TIPRANKS
·
May 19

European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading

MT Newswires Live
·
May 18

Morgan Stanley Remains a Buy on Ascendis Pharma (ASND)

TIPRANKS
·
May 18

Ascendis Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 16